While a number of studies have evaluated molecular differences in the tumor microenvironment of Black compared to White women with all subtypes of breast cancer or triple negative breast cancer [76,77,78], to our knowledge, no studies have investigated the role of the tumor microenvironment in disparate survival of women with HR+/HER2-breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.